The Centre has issued a nationwide advisory as the first case of the new coronavirus variant, JN.1, surfaced in India. The Centre has issued a crucial advisory to all states following the detection of the JN.1 variant in a 79-year-old woman from Thiruvananthapuram, Kerala. This comes hot on the heels...
A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccine’s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research.
#IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity
~HT.97~PR.152~
India is witnessing a surge in Covid-19 cases, particularly in Kerala, where the active cases have reached 4,054. The advent of the new sub-variant, JN.1, has spurred states to heighten precautionary..
On Friday, India witnessed a surge in its active Covid-19 caseload, nearing the 3,000-mark, with one reported death in Kerala. This increase follows the detection of the first case of the sub-variant..
As the nation sees another surge in Covid cases, a new sub-variant of the virus, identified as JN.1, is making headlines with 21 reported cases across different states. The sub-variant, a descendant of..
The Centre has asked states and union territories to maintain constant vigil amid an uptick in COVID-19 cases and the detection of the new JN.1 variant in the... DNA